Loading case study...

Back to Case Studies

Leading the Largest Foreign Investment into Cambridge, MA — US $4.0 Billion

Leading the Largest Foreign Investment into Cambridge, MA — US $4.0 Billion

Mr. Gonzalez joined Novartis in March 2000 after 9+ years at PepsiCo. After a year in the Consumer Health Business, Dr. Dan Vasella asked Mr. Gonzalez to become the Head of Human Resources for Research and Development.


Situation

Dr. Vasella had hired McKinsey to perform an analysis to guarantee Novartis would keep the top spot in Drug Discovery and Development. Their recommendation was that the Company needed to move the R&D group to the US — either the West Coast or the Boston area. This was complex because Novartis needed to preserve its Swiss Tax status that gave the Company a 10 percentage point advantage over US competitors.


Actors

  1. Dr. Dan Vasella
  2. Board of Directors of Novartis A.G.
  3. Head of Research
  4. Head of Development
  5. Head of Pharma
  6. Head of HR Novartis
  7. Every R&D department head that would have to relocate
  8. President of Harvard
  9. Governor of Massachusetts
  10. Mayor of Cambridge

Solution

Mr. Gonzalez led the negotiation and execution of the relocation of Novartis R&D from Basel, Switzerland to Cambridge, Massachusetts. The complexity was extraordinary — preserving Swiss tax status while building a US-based research campus required navigating regulatory, political, and organizational challenges simultaneously.


The investment grew from an initial $400M commitment to $4.0 billion — the largest single foreign investment in Massachusetts history. The scientific staff expanded from 400 to 1,400 researchers. The Cambridge campus became one of the world's leading biomedical research centers, anchoring the Kendall Square innovation ecosystem that exists today.